The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 12, 2008
Filed:
Jun. 29, 2001
Mark R. Schmitt, Trenton, NJ (US);
Donald R. Kirsch, Princeton, NJ (US);
Jane E. Harris, Pennington, NJ (US);
Carl F. Beyer, Chester, NY (US);
Klaus-jüergen Pees, Mainz, DE;
Paul A. Carter, Biberach an der Riss, DE;
Waldemar Pfrengle, Siebersbach, DE;
Guido Albert, Hackenheim, DE;
Mark R. Schmitt, Trenton, NJ (US);
Donald R. Kirsch, Princeton, NJ (US);
Jane E. Harris, Pennington, NJ (US);
Carl F. Beyer, Chester, NY (US);
Klaus-Jüergen Pees, Mainz, DE;
Paul A. Carter, Biberach an der Riss, DE;
Waldemar Pfrengle, Siebersbach, DE;
Guido Albert, Hackenheim, DE;
Wyeth, Madison, NJ (US);
Abstract
The invention provides a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal in need thereof which comprises administering to said mammal an effective amount of a substituted triazolopyrimidine derivative or a pharmaceutically acceptable salt thereof and further provides a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal in need thereof by interacting with tubulin and microtubules and promoting microtubule polymerization which comprises administering to said mammal an effective amount of a substituted triazolopyrimidine derivative or a pharmaceutically acceptable salt thereof.